For Immediate Release
For more information contact:
Feinstein Kean Healthcare
MIDDLEBURY COLLEGE STUDENT RAISES THOUSANDS TOWARD A CURE FOR MULTIPLE SCLEROSIS
Middlebury, VT September 2, 2005 Carrie Bryant, a sophomore at Middlebury College, organizes Carrie's Walk to Cure MS, an event that has raised over $13,000 to date to benefit the Accelerated Cure Project for Multiple Sclerosis.
Conceived and spearheaded by Ms. Bryant, Carrie's Walk to Cure MS is an event organized by volunteers who are students or faculty members at Middlebury College. On Saturday, October 15, 2005, walkers from throughout New England will join Carrie for a 4.3-mile walk that winds through the campus of the stately New England college. Carrie's Walk to Cure MS is expected to raise over $20,000 in its first year with all proceeds benefiting The Accelerated Cure Project for Multiple Sclerosis in their mission to cure Multiple Sclerosis (MS) by determining its causes.
Shortly after her 19th birthday in September 2004, Ms. Bryant was diagnosed with MS. Her determination and own personal search for a cure for MS has culminated in Carrie's Walk to Cure MS, which takes place one year after her diagnosis. Carrie hopes to build on the success of the inaugural Carrie's Walk to Cure MS and support the mission of the Accelerated Cure Project for Multiple Sclerosis each year. "This is something I felt that I needed to do. Accelerated Cure Project gives me the best chance for a Cure for MS", says Ms. Bryant. "I connected with them because their model made sense to me: you can't figure out how to cure MS until you determine what causes it." Carrie continues her studies this fall at Middlebury and her goal is to go to medical school and become a pediatric orthopedic doctor.
For more information, to participate, or to make a donation to Carrie's Walk to Cure MS, visit http://expansion.acceleratedcure.org/carrie
. At the walk, there will be a barbeque, refreshments, a DJ and a raffle featuring autographed memorabilia from Tom Brady, Dwight Evans, and Mike Krzyzewski. Walker registration for the day begins at 12:00 noon, and the walk commences at 1:00pm. All of the money raised through pledges, sponsors and donations will go to Accelerated Cure Project.
This event is made possible by Middlebury College and sponsors Milton CAT, Bank of America, Dow Industries, Griffon Greenhouse, and other generous donors.
About Accelerated Cure Project
Accelerated Cure Project for MS (ACP) is a nonprofit organization whose mission is to accelerate efforts toward a cure for multiple sclerosis (MS) by rapidly advancing research that determines its causes and mechanisms. We provide biomedical researchers with resources that catalyze open scientific collaboration and enable them to explore their novel research ideas rapidly and cost-efficiently. ACP’s strategic initiatives include the Multiple Sclerosis Discovery Forum and the ACP Repository, a large-scale collection of highly-characterized biosamples available to scientists at any organization conducting research that contributes to our mission. All results generated through analysis of Repository samples and data are contributed back to the ACP Repository Database, resulting in an increasingly valuable and comprehensive information resource that can be analyzed to reveal new insights about MS. To date, ACP has enrolled almost 3,000 participants into the Repository through a network of 10 MS clinical centers across the United States. The samples provided by people with MS and related disorders have supported more than 60 research studies worldwide and generated more than 150 million returned data points.
About Multiple Sclerosis
Multiple Sclerosis is a chronic demyelinating disorder of the central nervous system that often results in severe disability including the inability to walk, blindness, cognitive dysfunction, extreme fatigue, and other serious symptoms. MS affects more than 400,000 people in the US and two million individuals worldwide. The disorder occurs twice as often in women as in men. What causes MS is undetermined and no cure has yet been developed.